Center Laboratories (ROCO:4123) Cyclically Adjusted Book per Share: NT$0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4123 Center Laboratories Inc ROCO:4123
69 GF Score
Price NT$38.05
GF Value NT$43.04
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Center Laboratories Cyclically Adjusted Book per Share?

Center Laboratories ROCO:4123 +1.47% 69 Cyclically Adjusted Book per Share is NT$0.00 as of Mar. 2026. GuruFocus rates ROCO:4123 with a GF Score™ of 69/100 and a GF Value™ of NT$43.04 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Center Laboratories's adjusted book value per share for the three months ended in Mar. 2026 was NT$34.681. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Center Laboratories's average Cyclically Adjusted Book Growth Rate was 8.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Center Laboratories was 19.80% per year. The lowest was 9.90% per year. And the median was 18.90% per year.

As of today (2026-07-21), Center Laboratories's current stock price is NT$38.05. Center Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was NT$0.00. Center Laboratories's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Center Laboratories was 5.61. The lowest was 1.34. And the median was 2.32.


Center Laboratories  (ROCO:4123) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Center Laboratories was 5.61. The lowest was 1.34. And the median was 2.32.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Center Laboratories Cyclically Adjusted Book per Share Related Terms


Center Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Center Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Center Laboratories Cyclically Adjusted Book per Share Chart

Center Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.23 19.35 21.78 23.70 25.68

Center Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.30 24.76 25.25 25.68 0.00

ROCO:4123 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Cyclically Adjusted PB Ratio falls into.


ROCO:4123
69GF Score
Center Laboratories Inc ROCO:4123
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Center Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Center Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=34.681/330.2130*330.2130
=34.681

Current CPI (Mar. 2026) = 330.2130.

Center Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201606 11.952 241.018 16.375
201609 12.588 241.428 17.217
201612 11.749 241.432 16.069
201703 11.405 243.801 15.447
201706 11.489 244.955 15.488
201709 11.383 246.819 15.229
201712 11.750 246.524 15.739
201803 12.872 249.554 17.032
201806 11.365 251.989 14.893
201809 14.193 252.439 18.566
201812 21.450 251.233 28.193
201903 20.872 254.202 27.113
201906 20.040 256.143 25.835
201909 19.631 256.759 25.247
201912 21.016 256.974 27.006
202003 21.478 258.115 27.477
202006 22.500 257.797 28.820
202009 24.752 260.280 31.402
202012 26.918 260.474 34.125
202103 30.018 264.877 37.422
202106 31.704 271.696 38.532
202109 29.355 274.310 35.337
202112 28.272 278.802 33.485
202203 30.740 287.504 35.306
202206 28.627 296.311 31.902
202209 27.894 296.808 31.033
202212 27.967 296.797 31.116
202303 29.362 301.836 32.122
202306 28.057 305.109 30.365
202309 26.834 307.789 28.789
202312 27.408 306.746 29.505
202403 26.713 312.332 28.242
202406 25.027 314.175 26.305
202409 25.477 315.301 26.682
202412 23.852 315.605 24.956
202503 24.609 319.799 25.410
202506 22.767 322.561 23.307
202509 26.611 324.800 27.054
202512 35.480 324.054 36.154
202603 34.681 330.213 34.681

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$0.00 mean?
Center Laboratories (ROCO:4123) has a Cyclically Adjusted Book per Share of NT$0.00 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Center Laboratories and its competitors.
Is Center Laboratories' Cyclically Adjusted Book per Share too high?
Center Laboratories' current Cyclically Adjusted Book per Share is NT$0.00. Overall, Center Laboratories has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Center Laboratories' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Center Laboratories' Cyclically Adjusted Book per Share of NT$0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Center Laboratories and its competitors. Center Laboratories's current Cyclically Adjusted Book per Share is NT$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Center Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Center Laboratories (ROCO:4123) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$43.04, compared to a current price of NT$38.05 — trading 11.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$0.00. Center Laboratories' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Center Laboratories (ROCO:4123), the current Cyclically Adjusted Book per Share is NT$0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Center Laboratories (ROCO:4123) Overvalued in 2026?

Based on GuruFocus' analysis, Center Laboratories stock appears to be undervalued. The current stock price of NT$38.05 is trading 11.6% below its estimated GF Value™ of NT$43.04. GuruFocus considers Center Laboratories to be Modestly Undervalued.

Key valuation signals for ROCO:4123:

  • Cyclically Adjusted Book per Share: NT$0.00
  • GF Value™: NT$43.04 vs. price of NT$38.05 (11.6% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4123 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Center Laboratories Business Description

Address No. 3-2, Park Street, 7th floor, Nangang District, Taipei City, TWN, 115
Center Laboratories Inc is engaged in the manufacture and sale of various Western pharmaceuticals, including Western medicine manufacturing, wholesale, and retail. The Company operates through the following segments: Pharmaceutical Division, Biotechnology Venture Capital, and Glac Segment. The Pharmaceutical Division, which generates the majority of revenue, manufactures and sells various Western pharmaceuticals. The Biotechnology Venture Capital segment invests in domestic and foreign biotechnology undertakings, while the Glac Segment manufactures and sells probiotic products. The Company operates in Taiwan, Mainland China, and other regions, with Taiwan generating the majority of revenue.
69GF Score

Get the complete analysis for ROCO:4123

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.05
Price
NT$43.04
GF Value